Advancing Glaucoma Treatment: The Role of Selective Laser Trabeculoplasty (SLT)

Selective Laser Trabeculoplasty (SLT) is emerging as a leading option for managing intraocular pressure (IOP) in glaucoma patients. As an alternative to traditional topical medications for some patients, SLT offers a non-invasive approach that minimizes the need for daily eye drops, reducing the burden of medication adherence and minimizing ocular surface side effects. 

Recent research, including studies published in Glaucoma Today, has affirmed SLT’s efficacy as a first-line treatment and explored its long-term viability through repeat procedures. With advancements in laser technology and a growing body of evidence supporting its effectiveness, SLT is poised to play an increasingly significant role in glaucoma management.

SLT or Eye Drops: Which is the Better First-Line Treatment?

An international study explored the effectiveness of SLT versus eye drops as an initial treatment for glaucoma, focusing on their impact on intraocular pressure control and patient quality of life. While both methods effectively reduced IOP, SLT provided additional benefits, including fewer ocular surface-related side effects, such as irritation and dryness, which are common with prolonged eye drop use.

Patients who underwent SLT also reported improvements in social well-being, possibly due to the reduced burden of daily medication adherence. However, eye drops demonstrated slightly higher efficacy in reaching target IOP levels, making them a more immediate solution for certain patients requiring stringent pressure control.

Recent findings further reinforce SLT’s advantages. Studies have shown that SLT not only effectively lowers IOP but also minimizes daily fluctuations, which is crucial in preventing glaucoma progression. Additionally, research on optimizing SLT techniques emphasizes the importance of standardizing laser settings and patient selection criteria to maximize treatment success.

The Effectiveness of Repeat SLT

For patients who experience a waning effect from their initial SLT procedure, repeat SLT has been shown to be a viable option for continued IOP control. Research indicates that a second SLT treatment can effectively maintain target IOP levels without requiring medication, making it a valuable choice for those seeking a drop-free approach. 

Additionally, the cumulative effect of multiple SLT treatments may extend the duration of pressure control, providing an alternative to long-term medication dependence. With minimal side effects and no significant safety concerns, repeat SLT reinforces its role as a sustainable and effective glaucoma management strategy.

Research also assessed the benefits of repeat SLT for patients needing additional treatment. Findings showed that a second SLT procedure could sustain IOP control, offering a long-lasting, medication-free option for many patients. The duration of effect from repeat SLT was comparable to that of the initial procedure, reinforcing its viability as an ongoing treatment strategy.

Key Takeaways for Glaucoma Management

SLT continues to gain recognition as a strong alternative to eye drops, providing a non-medication approach with minimal side effects. Repeat treatments can help maintain its effectiveness over time, making it a valuable long-term option for glaucoma patients. Ongoing research will further refine treatment strategies, ensuring the best outcomes for individuals with glaucoma.

Visit Your Eye Doctor!

Regular consultations with an ophthalmologist are essential to determine the best approach for managing glaucoma safely. 

Visit Lifeview Glaucoma Center and consult Dr. Elisabeth Aponte, a board-certified ophthalmologist and surgeon, to explore the best treatment options for your eye health.

To learn more, visit Lifeview Glaucoma Center or read the full article at Glaucoma Today.